[In vitro effects of diclofenac and selective cyclooxygenase-2 inhibitors on prostaglandin release from inflamed bursa subacromialis tissue in patients with subacromial syndrome]

Orthopade. 2005 Mar;34(3):241-5, 247-9. doi: 10.1007/s00132-004-0732-2.
[Article in German]

Abstract

Background: To compare the in vitro effects of selective COX-2 inhibitors (L-745,337, NS-398 and DFU) and of COX-unspecific diclofenac on release of PGE(2 )and 6-keto-PGF(1alpha) from inflamed bursa subacromialis tissue (IBST) obtained from a total of 35 patients with shoulder impingement syndrome (SIS).

Patients and methods: Bursal specimens were incubated in the presence of drugs (0.01-1000 microM) for 20 min and 16 h.

Results: After 20 min 10 microM diclofenac significantly inhibited formation of PGE(2) and 6-keto-PGF(1alpha), whereas L-745,337 and NS-398 (10-1000 microM) induced significant inhibition only at concentrations > or =100 microM. In contrast to equimolar diclofenac, DFU (0.01-10 microM) induced no inhibition of bursal PGE(2) release but a dose-dependent, although statistically not significant inhibition after 16 h. The inhibitory potency of diclofenac (0.01-10 microM) was even more increased during long-term incubation showing greater inhibition than DFU at all concentrations studied.

Conclusion: The data suggest that in IBST in SIS in vitro the majority of PG is generated via the COX-1 pathway.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Acromion / drug effects
  • Acromion / metabolism*
  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Bursitis / metabolism*
  • Bursitis / prevention & control
  • Cyclooxygenase 2 Inhibitors / administration & dosage*
  • Diclofenac / administration & dosage*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prostaglandins / biosynthesis*
  • Shoulder Impingement Syndrome / drug therapy
  • Shoulder Impingement Syndrome / metabolism*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Prostaglandins
  • Diclofenac